Wegovy Use Video Guides: What the Instructions Miss

The myth that a video alone is enough preparation

Spend five minutes on any video platform and you'll find dozens of clips showing someone clicking a Wegovy pen against their abdomen. They make it look effortless, and to be fair, the injection itself usually is. The misconception is that watching the technique is the whole job of preparation. It isn't.

What a video can't show you is the clinical context: why the 0.25mg starting dose exists (it's there to let your system adjust, not to produce immediate weight loss), how to handle a dose you took at the wrong time, or what the pen feels like when it hasn't worked properly. The NHS patient information for semaglutide covers the clinical detail a video skips, and it's worth reading alongside any demonstration you watch.

There's also the practical reality that your first pen may arrive on a Monday after a bank holiday weekend, when nerves about starting are highest and support feels furthest away. Knowing the process before the pen arrives means you're not searching for answers at 8pm. If you're preparing to start, the full Wegovy overview sets out what to expect across the first weeks of treatment.

What a proper injection video should actually show you

Good instructional content, including the video guides produced alongside Wegovy's UK approval, covers several steps that matter in sequence. The pen should come out of the fridge a few minutes before use, injecting a cold solution is perfectly safe but can sting more. Check the window: the liquid should be clear and colourless. Don't shake it.

Choose an injection site: the abdomen (at least 5cm from the navel), the front of the thigh or the upper arm. Each week, move to a different site within the same area, or rotate between areas. Using the same spot repeatedly can cause localised tissue changes over time. Remove the cap, place the pen flat against clean skin, press and hold the button until the injection is complete, and keep holding for the full count specified in your leaflet. The most common user error is pulling the pen away a second or two early, before the full dose has been delivered.

For a close-up walkthrough of the pen mechanism itself, the step-by-step injection guide covers the process in detail, and a broader collection of Wegovy video resources includes demonstrations across pen types.

Semaglutide injection technique versus what works in practice

The licensed technique for semaglutide injection is consistent across Wegovy pens, but there are a few gaps between the official instructions and what users actually encounter.

First: missed doses. If you remember within five days of your usual day, take the injection and then return to your normal weekly schedule. If it's been more than five days, skip that week's dose and take the next one as planned, do not double up. The dose timing and any adjustments should always be confirmed with your prescriber; the Patient Information Leaflet is the authoritative guide, and this administration guide covers the pen steps alongside that context.

Second: the pen clicking without the window changing colour, or the liquid not moving. This almost always means the pen wasn't held firmly enough against the skin, or the count was too short. It's not dangerous, but if you're unsure whether a dose was delivered, don't inject again without speaking to your prescriber first.

Third: the site reaction. A small red mark, mild itching or firmness at the injection site is common and usually resolves within a day or two. Rotating sites reduces it. Persistent swelling, significant pain or signs of an allergic reaction (including rash, difficulty breathing or swelling of the face) are reasons to seek medical attention promptly.

Where clinical oversight fits around the technique

Knowing how to inject Wegovy is a practical skill. Knowing whether Wegovy is the right treatment for you at this point, at this dose, alongside your other medicines and health conditions, that's a clinical judgement. The two things are related but not the same.

Wegovy is licensed for weight management in adults with a BMI of 30 or above, or 27 or above alongside a weight-related health condition. The semaglutide dose begins low and is titrated by the prescriber, typically in four-week steps. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. None of this is decided by a video; it's decided by a prescriber who reviews your full picture before any pen is dispatched.

At nume, a GPhC-registered Independent Prescriber reads every consultation personally on the day it's submitted. There are no automated approvals. If you're at the stage of thinking about how to access Wegovy through a regulated online pharmacy, understanding what clinical review actually involves is part of making a safe choice. The semaglutide information page covers eligibility, the licensed dose schedule and what clinical assessment looks at. For context on what a private prescription for Wegovy typically costs, the weight loss treatments overview sets that out clearly.

The MHRA's published guidance on GLP-1 medicines is also worth reading, it explains why these are prescription-only medicines assessed on clinical need, not over-the-counter products. If you have questions before starting or during treatment, our aftercare team is available seven days a week.